---
title: ICBio vs Innovate Research
slug_a: icbiocro
slug_b: innovate-research
site: cro
review_signal_gate: closed
canonical_path: /compare/icbiocro/innovate-research
---

# ICBio vs Innovate Research

Side-by-side profile data from each company listing on this directory.

## ICBio

- Profile: [/companies/icbiocro](/companies/icbiocro)

ICBio — ICBio is a Bengaluru-based CRO offering bioavailability/bioequivalence studies, phase II–IV clinical trials, and LC-MS/MS bioanalysis. The excerpts cite regulatory approvals from DCGI-CDSCO, ANVISA, and EMA.

Services: 14. Modalities: 1. Indications: 0. Locations: 1. Certifications: 5. The strongest documented coverage currently appears in services (14).

### Services

- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Central Laboratory Services
- Regulatory Affairs

### Modalities

- Small Molecule

### Indications

- Data not yet provided.

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## Innovate Research

- Profile: [/companies/innovate-research](/companies/innovate-research)

Innovate Research — Indian CRO providing end-to-end clinical trial services (Phase I–IV), regulatory support, medical writing, biostatistics, data management, and biospecimen procurement across pharmaceuticals, biologics, medical devices, and nutraceuticals.

Services: 11. Modalities: 3. Indications: 0. Locations: 5. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Other)
- Vaccine

### Indications

- Data not yet provided.

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Full-Service Outsourcing (FSO)